Bone marrow involvement in follicular lymphoma: Comparison of histology and flow cytometry as staging procedures

References

• MacManus M P, Hoppe R T. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 1996; 14: 1282–1290
   PubMed Web of Science ®Google Scholar
• Miller T P, Dahlberg S, Cassady J R, Adelstein D J, Spier C M, Grogan T M, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 1998; 339: 21–26
   PubMed Web of Science ®Google Scholar
• Vaughan Hudson B, Vaughan Hudson G, MacLennan K A, Anderson L, Linch D C. Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. Br J Cancer 1994; 69: 1088–1093
   PubMed Web of Science ®Google Scholar
• Juneja S K, Wolf M M, Cooper I A. Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma. J Clin Pathol 1990; 43: 630–632
   PubMed Web of Science ®Google Scholar
• Duggan P R, Easton D, Luider J, Auer I A. Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphology. Cancer 2000; 88: 894–899
   PubMed Web of Science ®Google Scholar
• Dunphy C H. Combining morphology and flow cytometric immunophenotyping to evaluate bone marrow specimens for B-cell malignant neoplasms. Am J Clin Pathol 1998; 109: 625–630
   PubMed Web of Science ®Google Scholar
• Hanson C A, Kurtin P J, Katzmann J A, Hoyer J D, Li C Y, Hodnefield J M, et al. Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. Blood 1999; 94: 3889–3896
   PubMed Web of Science ®Google Scholar
• Naughton M J, Hess J L, Zutter M M, Bartlett N L. Bone marrow staging in patients with non-Hodgkin's lymphoma: is flow cytometry a useful test?. Cancer 1998; 82: 1154–1159
   PubMed Web of Science ®Google Scholar
• Palacio C, Acebedo G, Navarrete M, Ruiz-Marcellan C, Sanchez C, Blanco A, et al. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas. Haematologica 2001; 86: 934–940
   PubMed Web of Science ®Google Scholar
• Perea G, Altes A, Bellido M, Aventin A, Bordes R, Ayats R, et al. Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL). Histopathology 2004; 45: 268–274
   PubMed Web of Science ®Google Scholar
• Stacchini A, Demurtas A, Godio L, Martini G, Antinoro V, Palestro G. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B Clin Cytom 2003; 54: 10–18
   PubMed Web of Science ®Google Scholar
• Henrique R, Achten R, Maes B, Verhoef G, De Wolf-Peeters C. Guidelines for subtyping small B-cell lymphomas in bone marrow biopsies. Virchows Arch 1999; 435: 549–558
   PubMed Web of Science ®Google Scholar
• Schmid C, Isaacson P G. Bone marrow trephine biopsy in lymphoproliferative disease. J Clin Pathol 1992; 45: 745–750
   PubMed Web of Science ®Google Scholar
• Kremer M, Sandherr M, Geist B, Cabras A D, Hofler H, Fend F. Epstein-Barr virus-negative Hodgkin's lymphoma after mycosis fungoides: molecular evidence for distinct clonal origin. Mod Pathol 2001; 14: 91–97
   PubMed Web of Science ®Google Scholar
• Borowitz M J, Bray R, Gascoyne R, Melnick S, Parker J W, Picker L, et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. Cytometry 1997; 30: 236–244
   PubMedGoogle Scholar
• Stelzer G T, Marti G, Hurley A, McCoy P, Jr, Lovett E J, Schwartz A. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. Cytometry 1997; 30: 214–230
   PubMedGoogle Scholar
• Stewart C C, Behm F G, Carey J L, Cornbleet J, Duque R E, Hudnall S D, et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations. Cytometry 1997; 30: 231–235
   PubMedGoogle Scholar
• Cheson B D, Horning S J, Coiffier B, Shipp M A, Fisher R I, Connors J M, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244
   PubMed Web of Science ®Google Scholar
• Campbell J K, Matthews J P, Seymour J F, Wolf M M, Juneja S K. Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma. Ann Oncol 2003; 14: 273–276
   PubMed Web of Science ®Google Scholar
• McKenna R W, Washington L T, Aquino D B, Picker L J, Kroft S H. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood 2001; 98: 2498–2507
   PubMed Web of Science ®Google Scholar
• Cook J R, Craig F E, Swerdlow S H. bcl-2 expression by multicolor flow cytometric analysis assists in the diagnosis of follicular lymphoma in lymph node and bone marrow. Am J Clin Pathol 2003; 119: 145–151
   PubMed Web of Science ®Google Scholar